ESR1 and breast carcinoma: But across all breast tumors; ER/PR-positive; lymph node-negative or non-metastatic disease, Kim et al. report there is an association between high mir-744 expression and increased survival46, which supports the role of miR-744 as a tumor suppressor in breast cancer.